Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

Memorial Sloan Kettering Cancer Center, New York

Sarah Cannon Research Institute, Nashville

University of Wisconsin Carbone Cancer Center, Madison

MD Anderson Cancer Center, Houston

USC Norris Comprehensive, Los Angeles

University of California Los Angeles Department of Medicine, Los Angeles

Providence Cancer Institute Franz Clinic, Portland

Fred Hutchinson Cancer Center, Seattle

Yale New Haven Hospital, New Haven